|
Vitruvia Medical AG / Key word(s): Capital Increase/Corporate Action Vitruvia Medical AG: successfull capital increase and strengthening of the financial structure 15-Dec-2025 / 16:42 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News – a service of EQS Group. The issuer is solely responsible for the content of this announcement. Ad hoc announcement Vitruvia Medical AG December 15, 2025
Vitruvia Medical AG successfully completes capital increase and strengthens its financial structure Vitruvia Medical AG announces that a capital increase was successfully completed on December 15, 2025. The newly created capital was used in full to repay the convertible bond due at the beginning of December. This measure strengthened the company’s equity and significantly reduced its debt. The improved capital structure secures the long-term financing of Vitruvia Medical AG and contributes significantly to the company’s economic stability. The Board of Directors of Vitruvia AG
End of Inside Information 15-Dec-2025 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Vitruvia Medical AG |
| Kesselackerstr. 18 | |
| 5611 Anglikon | |
| Switzerland | |
| Phone: | +41 44 915 33 78 |
| E-mail: | kontakt@vitruvia-med.com |
| Internet: | www.vitruvia-med.com |
| ISIN: | CH0461931419 |
| WKN: | A2PDWF |
| Listed: | Regulated Unofficial Market in Munich |
| EQS News ID: | 2246030 |
| End of Announcement | EQS News Service |
|
|
2246030 15-Dec-2025 CET/CEST